Your session is about to expire
← Back to Search
Alkylating agents
Chemotherapy + Stem Cell Transplant for Ovarian Cancer
Phase 1 & 2
Waitlist Available
Research Sponsored by Herbert Irving Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Performance status ECOG 0-1
No brain metastases
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is studying how well chemotherapy and autologous peripheral stem cell transplantation work in treating patients with ovarian cancer.
Who is the study for?
This trial is for adults over 18 with recurrent or persistent ovarian, fallopian tube, or primary peritoneal cancer who've had at least 3 rounds of platinum-based chemo. They must have a certain level of tumor marker CA125 and be in good health otherwise. Pregnant women and those with serious illnesses that could interfere with treatment are excluded.Check my eligibility
What is being tested?
The study is testing the effectiveness of high-dose chemotherapy combined with autologous peripheral stem cell transplantation (using the patient's own stem cells) to treat patients whose cancer has come back or didn't respond to initial treatments.See study design
What are the potential side effects?
Chemotherapy can cause side effects like nausea, fatigue, hair loss, increased risk of infection due to low blood counts, and organ damage. Stem cell transplantation may lead to complications such as infections while immune system recovers.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am fully active or can carry out light work.
Select...
My cancer has not spread to my brain.
Select...
My kidney function tests are within normal limits.
Select...
I am 18 years old or older.
Select...
My ovarian, fallopian tube, or peritoneal cancer has returned after initial treatment.
Select...
My liver function tests are within normal limits.
Select...
My stage IV cancer responded completely to platinum-based treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,666 Previous Clinical Trials
40,925,975 Total Patients Enrolled
285 Trials studying Ovarian Cancer
73,736 Patients Enrolled for Ovarian Cancer
Herbert Irving Comprehensive Cancer CenterLead Sponsor
34 Previous Clinical Trials
1,059 Total Patients Enrolled
2 Trials studying Ovarian Cancer
65 Patients Enrolled for Ovarian Cancer
Amy D. Tiersten, MDStudy ChairHerbert Irving Comprehensive Cancer Center
5 Previous Clinical Trials
169 Total Patients Enrolled
3 Trials studying Ovarian Cancer
104 Patients Enrolled for Ovarian Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am fully active or can carry out light work.I do not have any serious illnesses that would stop me from receiving treatment.My cancer has not spread to my brain.My kidney function tests are within normal limits.I am 18 years old or older.I am not taking acetaminophen currently.I have no previous cancers except possibly treated skin, cervical, or low-risk breast cancer.My ovarian, fallopian tube, or peritoneal cancer has returned after initial treatment.My liver function tests are within normal limits.My heart's pumping ability is at least 45%.My stage IV cancer responded completely to platinum-based treatment.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available positions for participants in this trial?
"No, this particular clinical trial is not currently recruiting patients. Although, there are 715 other trials that are looking for participants right now. Originally posted on 1/1/1997 and last updated on 1/3/2014, this trial's information is hosted on clinicaltrials.gov."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger